SAN FRANCISCO, CA USA (UroToday.com) - Presented by S. Nilsson,1 N. Vogelzang,2 O. Sartor,3 D. Bottomley,4 R. Coleman,5 I. Skjorestad,6 M. Wahba,7 and C. Parker8 at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
1Karolinska University Hospital, Stockholm, Sweden; 2Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA; 3Tulane Cancer Center, New Orleans, LA, USA; 4St. James Hospital, Leeds, UK; 5Weston Park Hospital, Sheffield, UK; 6Algeta ASA, Oslo, Norway; 7Bayer HealthCare, Whippany, NJ, USA; 8The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK
Click HERE to read an exclusive report by a UroToday medical writer
Click HERE to listen to an exclusive interview with one of the authors of this study